End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention?

IF 0.6 Q4 ONCOLOGY
Anjana Joel, Ashish Singh, Julie Hepzibah, Antony Devasia, Santosh Kumar, Birla Roy Gnanamuthu, Anuradha Chandramohan, Arun Jacob Philip George, Nirmal Thampi John, Bijesh Yadav, Ajoy Oommen John, Josh Thomas Georgy, Subhashini John, Raju Titus Chacko
{"title":"End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention?","authors":"Anjana Joel,&nbsp;Ashish Singh,&nbsp;Julie Hepzibah,&nbsp;Antony Devasia,&nbsp;Santosh Kumar,&nbsp;Birla Roy Gnanamuthu,&nbsp;Anuradha Chandramohan,&nbsp;Arun Jacob Philip George,&nbsp;Nirmal Thampi John,&nbsp;Bijesh Yadav,&nbsp;Ajoy Oommen John,&nbsp;Josh Thomas Georgy,&nbsp;Subhashini John,&nbsp;Raju Titus Chacko","doi":"10.1055/s-0041-1735480","DOIUrl":null,"url":null,"abstract":"<p><p>Anjana Joel<b>Context</b>  Patients with seminoma present with advanced disease. End-of-treatment (EOT) positron emission tomography-computed tomography (PET-CT) is done to assess response and direct management of post-chemotherapy residual masses. <b>Purpose</b>  This article assesses the utility of EOT PET-CT in the management of post-chemotherapy residual lymph nodal masses seminoma. <b>Materials and Methods</b>  We analyzed all patients with seminoma who underwent an EOT PET-CT from January 2015 to January 2020 at our center and calculated the positive predictive value (PPV) and negative predictive value (NPV) of EOT PET-CT in the entire cohort of patients and among subgroups. <b>Results</b>  A total of 34 male patients underwent EOT PET-CT. Fourteen (41.2%) were stratified as good risk and 20 (58.8%) as intermediate risk. The median follow-up was 23 months (interquartile range: 9.75-53 months). In 23 patients there were residual masses of size more than 3 cm at the EOT PET scan. EOT PET was positive as per the SEMPET criteria in 18 (78%) out of 23 patients. None underwent retroperitoneal lymph node dissection. All four who underwent image-guided biopsy, showed only necrosis on pathology. One patient with positive mediastinal node (standardized uptake value 13.6) had granulomatous inflammation. There was no relapse or progression during this period of follow-up. The NPV for EOT PET-CT for the entire cohort, > 3 cm, and > 6 weeks cutoff were 100%, respectively. The PPV for EOT PET-CT for the entire cohort, > 3 cm residual mass, and > 6 weeks cutoff were 8.7, 11.11, and 6.67%, respectively. <b>Conclusion</b>  EOT PET-CT has a low PPV and high NPV in predicting viable tumor in post-chemotherapy residual masses among patients with seminomatous germ cell tumors. If required, EOT PET positivity can be confirmed by a biopsy or reassessed with a repeat PET-CT imaging to document persistent disease prior to further intervention.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"11 4","pages":"315-321"},"PeriodicalIF":0.6000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/11/10-1055-s-0041-1735480.PMC9902077.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South Asian Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0041-1735480","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Anjana JoelContext  Patients with seminoma present with advanced disease. End-of-treatment (EOT) positron emission tomography-computed tomography (PET-CT) is done to assess response and direct management of post-chemotherapy residual masses. Purpose  This article assesses the utility of EOT PET-CT in the management of post-chemotherapy residual lymph nodal masses seminoma. Materials and Methods  We analyzed all patients with seminoma who underwent an EOT PET-CT from January 2015 to January 2020 at our center and calculated the positive predictive value (PPV) and negative predictive value (NPV) of EOT PET-CT in the entire cohort of patients and among subgroups. Results  A total of 34 male patients underwent EOT PET-CT. Fourteen (41.2%) were stratified as good risk and 20 (58.8%) as intermediate risk. The median follow-up was 23 months (interquartile range: 9.75-53 months). In 23 patients there were residual masses of size more than 3 cm at the EOT PET scan. EOT PET was positive as per the SEMPET criteria in 18 (78%) out of 23 patients. None underwent retroperitoneal lymph node dissection. All four who underwent image-guided biopsy, showed only necrosis on pathology. One patient with positive mediastinal node (standardized uptake value 13.6) had granulomatous inflammation. There was no relapse or progression during this period of follow-up. The NPV for EOT PET-CT for the entire cohort, > 3 cm, and > 6 weeks cutoff were 100%, respectively. The PPV for EOT PET-CT for the entire cohort, > 3 cm residual mass, and > 6 weeks cutoff were 8.7, 11.11, and 6.67%, respectively. Conclusion  EOT PET-CT has a low PPV and high NPV in predicting viable tumor in post-chemotherapy residual masses among patients with seminomatous germ cell tumors. If required, EOT PET positivity can be confirmed by a biopsy or reassessed with a repeat PET-CT imaging to document persistent disease prior to further intervention.

Abstract Image

Abstract Image

精原细胞瘤化疗后肿块患者的治疗结束FDG PET-CT (EOT-PET):我们能避免进一步干预吗?
Anjana JoelContext精原细胞瘤患者表现为疾病晚期。治疗结束(EOT)正电子发射断层扫描-计算机断层扫描(PET-CT)用于评估化疗后残余肿块的反应和直接管理。目的评价EOT PET-CT在化疗后精原细胞瘤残留淋巴结肿块治疗中的应用价值。材料和方法我们分析了2015年1月至2020年1月在我们中心接受EOT PET-CT检查的所有精原细胞瘤患者,并计算了整个队列患者和亚组之间EOT PET-CT的阳性预测值(PPV)和阴性预测值(NPV)。结果34例男性患者行EOT PET-CT检查。14例(41.2%)为良好风险,20例(58.8%)为中度风险。中位随访为23个月(四分位数间距:9.75-53个月)。在23例患者中,EOT PET扫描显示残余肿块大小超过3cm。根据SEMPET标准,23例患者中有18例(78%)EOT PET阳性。无一例接受腹膜后淋巴结清扫。所有4例患者均行图像引导活检,病理上仅显示坏死。1例纵隔淋巴结阳性(标准化摄取值13.6)伴有肉芽肿性炎症。随访期间无复发或进展。EOT PET-CT对整个队列、> 3 cm和> 6周的NPV分别为100%。EOT PET-CT对整个队列、> 3cm残余肿块和> 6周截止的PPV分别为8.7、11.11%和6.67%。结论EOT PET-CT对半瘤性生殖细胞肿瘤化疗后残留肿块的预测具有低PPV和高NPV的优势。如有需要,EOT PET阳性可通过活检确认,或在进一步干预前通过重复PET- ct成像重新评估,以确定是否存在持续性疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
80
审稿时长
35 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信